| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/08/2026 | ±9.0% | +10.0% | under-priced |
| 09/08/2026 | ±9.0% | +10.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $-2.51 | $0 | $-15M |
| Q2 FY2025 | — | $0 | $-14M |
BRVE (BRVE) reports in 40 days, with the next report estimated for 12/07/2026. Across the last 2 reports, options priced an average ±9.0% earnings move while the stock actually moved 10.0% on average — the market has tended to under-price BRVE's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads BRVE as a neutral at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →